Product (Zilpaterol, Ractopamine)
The ractopamine segment is estimated to hold 56% share of the of the global beta agonist feed additives market by 2036, because of the numerous benefits associated with the product. The amino acid ractopamine has been shown to stimulate lean muscle growth. About 80% of all beef, swine, and turkeys grown in the US are fed ractopamine (RAC). In addition, it is more efficient than zilpaterol and enables livestock to grow rapidly while consuming less feed. As a result, more lean meat is found in cattle which is projected to drive the growth of this segment over the forecast period.
Animal Type (Poultry, Cattle, Sheep, Swine, Buffalo)
The cattle segment in the beta agonist feed additives market is anticipated to garner significant revenue share. The segment will develop as a result of consumer demand for cow products, such as milk and meat, which are important sources of protein for diets. Dairy products and milk are in constant demand. Cattle therefore need to be given all the necessary minerals, trace elements, and health supplements for improved growth performance to meet the increasing demand for animal-based goods. Regular animal diets produce more, but to boost the cattle's general health and productivity, certain feed additives need to be added. All these factors are responsible for the segment’s growth.
Our in-depth analysis of the global beta agonist feed additives market includes the following segments:
Product |
|
Animal Type |
|
Form |
|
Author Credits: Parul Atri
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?